Syra Health Statistics
Total Valuation
Syra Health has a market cap or net worth of $6.76 million. The enterprise value is $3.73 million.
| Market Cap | 6.76M |
| Enterprise Value | 3.73M |
Important Dates
The next estimated earnings date is Monday, May 13, 2024, before market open.
| Earnings Date | May 13, 2024 |
| Ex-Dividend Date | n/a |
Share Statistics
Syra Health has 6.56 million shares outstanding. The number of shares has increased by 60.40% in one year.
| Shares Outstanding | 6.56M |
| Shares Change (YoY) | +60.40% |
| Shares Change (QoQ) | +11.87% |
| Owned by Insiders (%) | n/a |
| Owned by Institutions (%) | n/a |
| Float | n/a |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 1.23 |
| Forward PS | 0.66 |
| PB Ratio | 1.68 |
| P/FCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 0.68 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 5.25, with a Debt / Equity ratio of 0.06.
| Current Ratio | 5.25 |
| Quick Ratio | 4.83 |
| Debt / Equity | 0.06 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -53.73 |
Financial Efficiency
Return on equity (ROE) is -641.00% and return on invested capital (ROIC) is -67.76%.
| Return on Equity (ROE) | -641.00% |
| Return on Assets (ROA) | -101.10% |
| Return on Capital (ROIC) | -67.76% |
| Revenue Per Employee | $70,707 |
| Profits Per Employee | -$37,671 |
| Employee Count | 78 |
| Asset Turnover | 1.90 |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
| Beta (1Y) | n/a |
| 52-Week Price Change | n/a |
| 50-Day Moving Average | 1.81 |
| 200-Day Moving Average | n/a |
| Relative Strength Index (RSI) | 32.39 |
| Average Volume (30 Days) | 1,925,290 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Syra Health had revenue of $5.52 million and -$2.94 million in losses. Loss per share was -$0.60.
| Revenue | 5.52M |
| Gross Profit | 1.41M |
| Operating Income | -2.89M |
| Pretax Income | -2.94M |
| Net Income | -2.94M |
| EBITDA | -2.84M |
| EBIT | -2.88M |
| Loss Per Share | -$0.60 |
Balance Sheet
The company has $3.28 million in cash and $248,103 in debt, giving a net cash position of $3.03 million or $0.46 per share.
| Cash & Cash Equivalents | 3.28M |
| Total Debt | 248,103 |
| Net Cash | 3.03M |
| Net Cash Per Share | $0.46 |
| Equity / Book Value | 4.01M |
| Book Value Per Share | 0.61 |
| Working Capital | 3.87M |
Cash Flow
In the last 12 months, operating cash flow was -$2.76 million and capital expenditures -$15,251, giving a free cash flow of -$2.77 million.
| Operating Cash Flow | -2.76M |
| Capital Expenditures | -15,251 |
| Free Cash Flow | -2.77M |
| FCF Per Share | -$0.57 |
Margins
Gross margin is 25.60%, with operating and profit margins of -52.36% and -53.28%.
| Gross Margin | 25.60% |
| Operating Margin | -52.36% |
| Pretax Margin | -53.28% |
| Profit Margin | -53.28% |
| EBITDA Margin | -51.42% |
| EBIT Margin | -52.30% |
| FCF Margin | -50.30% |
Dividends & Yields
Syra Health does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -60.40% |
| Shareholder Yield | -60.40% |
| Earnings Yield | -43.45% |
| FCF Yield | -41.03% |
Analyst Forecast
| Price Target | n/a |
| Price Target Difference | n/a |
| Analyst Consensus | n/a |
| Analyst Count | n/a |
| Revenue Growth Forecast (5Y) | n/a |
| EPS Growth Forecast (5Y) | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
Syra Health has an Altman Z-Score of 3.15 and a Piotroski F-Score of 3.
| Altman Z-Score | 3.15 |
| Piotroski F-Score | 3 |